Contingency Management for Alcohol Use Disorders

Alcohol Use Disorder Clinical Trial

Official title:

Contingency Management for Alcohol Use Disorders

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02135237
• Other study ID #: 12-204H-2
• Secondary ID: R01AA021446
• Status: Completed
• Phase: N/A
• Start date: January 2014
• Est. completion date: June 2019

Study information

• Verified date: October 2019
• Source: UConn Health
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 120
• Est. completion date: June 2019
• Est. primary completion date: June 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• age 18 years or older

• current diagnosis of alcohol use disorder and self report of recent alcohol use

• pass an informed consent quiz

• agree to wear a SCRAMx monitor for 12 weeks

• have a standard SCRAMx compatible phone line in their home or agree to attend the clinic weekly for brief research visits/downloads

• agree to sign an off-campus property transfer form and return SCRAMx equipment

Exclusion Criteria:

• serious, uncontrolled psychiatric illness

• in recovery from pathological gambling

• have an unstable address

• intend to participate in activities incompatible with SCRAMx over the next 3 months

• are wearing SCRAMx for legal purposes

Related Conditions & MeSH terms

• Alcohol Drinking
• Alcohol Use Disorder
• Alcoholism
• Contingency Management
• Disease

Intervention

Behavioral:
• Prize Contingency Management for Alcohol Abstinence
The systematic reinforcement of desired behaviors and the withholding of reinforcement for undesired behaviors
• Standard Care

Locations

Country	Name	City	State
United States	Farrell Treatment Center	New Britain	Connecticut
United States	The Hospital of Central Connecticut at New Britain General	New Britain	Connecticut
United States	Behavioral Health Network, Inc.	Springfield	Massachusetts

Sponsors (2)

Lead Sponsor	Collaborator
UConn Health	National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	longest duration of abstinence from alcohol	objective report of alcohol use as measured by SCRAMx device	three months